Search Within

Andrew D Seidman

  1. "Nursing"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (8)
  3. Conference Paper (2)
Groups
  1. Breast Medicine Service (20)
  2. Department of Medicine (20)
  3. Nursing (20)
  4. Solid Tumor Oncology Division (20)
  5. Survivorship Research (17)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)

More Groups

People
  1. Clifford Hudis (15)
  2. Larry Norton (14)
  3. Violante Currie (9)
  4. Teresa Gilewski (8)
  5. Tzy-Jyun Yao (8)
  6. Antonella Surbone (7)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2011 (1)
  4. 2007 (1)
  5. 2001 (3)
  6. 1999 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Breast Cancer Research and Treatment (3)
  3. Cancer Investigation (2)
  4. Annals of the New York Academy of Sciences (1)
  5. Cancer Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Springer (3)
  3. American Association for Cancer Research (2)
  4. Informa Healthcare (2)
  5. Oxford University Press (2)
  6. Elsevier Inc. (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integration of multi-modality treatment planning for early stage breast cancer (BC) into Watson for Oncology, a Decision Support System: Seeing the forest and the trees
    Meeting Abstract

    Seidman, A. D.; Pilewskie, M. L.; Robson, M. E.; Kelvin, J. F.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Fu, J.; Keesing, J.; Caroline, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. q 2-weekly vs. q 3-weekly nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for metastatic breast cancer
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Forero-Torres, A.; Wright, G.; Hackney, M. H.; Clawson, A.; Schofield, D.; Iglesias, J.; Hudis, C. A.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Randomized phase II trial of three dosing schedules of nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer: An initial interim safety report
    Meeting Abstract

    Conlin, A. K.; Seidman, A. D.; Moynahan, M. E.; Traina, T.; Mace, J. R.; Meiri, E.; Bach, A.; Edwards, C.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCl, in metastatic breast cancer
    Journal Article

    Mùˆnster, P. N.; Buzdar, A.; Dhingra, K.; Enas, N.; Ni, L.; Major, M.; Melemed, A.; Seidman, A.; Booser, D.; Theriault, R.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Theodoulou, M.; Moynahan, M. E.; Currie, V.; Moasser, M.; Sklarin, N.; Gilewski, T.; D'Andrea, G.; Salvaggio, R.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
    Journal Article

    Van Poznak, C.; Seidman, A. D.; Reidenberg, M. M.; Moasser, M. M.; Sklarin, N.; Van Zee, K.; Borgen, P.; Gollub, M.; Bacotti, D.; Yao, T. J.; more...
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Phase II trial of weekly 1-hour taxol and herceptin for metastatic breast cancer: Toward further exploitation of proven synergistic antitumor activity
    Meeting Abstract

    Seidman, A. D.; Fornier, M.; Hudis, C.; Theodoulou, M.; Surbone, A.; Moynahan, M. E.; Currie, V.; Moasser, M.; Chin, J.; Bach, A.; more...
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • Preliminary results of a phase 1 study of a third-generation selective estrogen receptor modulator (SERM3, LY353381.HC1) in refractory, metastatic breast cancer
    Meeting Abstract

    Hudis, C.; Buzdar, A.; Munster, P.; Booser, D.; Seidman, A.; Theriault, R.; Moasser, M.; Frye, D.; Surbone, A.; Major, M.; more...
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
    Journal Article

    Hudis, C.; Fornier, M.; Riccio, L.; Lebwohl, D.; Crown, J.; Gilewski, T.; Surbone, A.; Currie, V.; Seidman, A.; Reichman, B.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save